Peter Soparkar, Chief Operating Officer of Adverum Biotechnologies ($ADVM), made one open market purchase of shares worth $211,000 in the last year, with the most recent on December 5, 2025. This ranks him 1,489th among 4,983 insiders by purchase value, below the average of $1.5 million across 3.29 transactions. He also sold shares once for $5,920, most recently on May 15, 2025, ranking 11,378th among 11,678 insiders by sale value, well under the average of $8.6 million across 6.37 transactions.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | D | Stock Option (Right to Buy) | 40000 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.17% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | D | Stock Option (Right to Buy) | 38500 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.16% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | D | Stock Option (Right to Buy) | 15999 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.07% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | D | Stock Option (Right to Buy) | 13999 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.06% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | D | Stock Option (Right to Buy) | 4074 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.02% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | D | Stock Option (Right to Buy) | 45000 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.19% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | D | Stock Option (Right to Buy) | 39476 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.17% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | U | Common Stock | 80189 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.34% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | U | Common Stock - Restricted Stock Units | 13125 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.06% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | A | Common Stock - Performance Stock Units | 150000 | $0.00 | 157,333.0000 | 23,487,000 | 2045.55% | 0.64% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | U | Common Stock - Performance Stock Units | 157333 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.67% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | D | Stock Option (Right to Buy) | 40000 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.17% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | D | Stock Option (Right to Buy) | 64394 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.27% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | D | Stock Option (Right to Buy) | 78750 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.34% |
| Dec. 5, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | P | Common Stock | 50000 | $4.22 | 80,189.0000 | 23,487,000 | 165.62% | 0.21% |
| June 17, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | A | Stock Option (Right to Buy) | 16384 | $0.00 | 16,384.0000 | 19,782,000 | 9999.99% | 0.08% |
| June 17, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | D | Stock Option (Right to Buy) | 45000 | $0.00 | 0.0000 | 19,782,000 | 100.00% | 0.23% |
| June 17, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | A | Stock Option (Right to Buy) | 45000 | $0.00 | 45,000.0000 | 19,782,000 | 9999.99% | 0.23% |
| June 17, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | D | Stock Option (Right to Buy) | 40000 | $0.00 | 0.0000 | 19,782,000 | 100.00% | 0.20% |
| June 17, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 19,782,000 | 9999.99% | 0.20% |
| June 17, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | D | Stock Option (Right to Buy) | 4074 | $0.00 | 0.0000 | 19,782,000 | 100.00% | 0.02% |
| June 17, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | A | Stock Option (Right to Buy) | 4074 | $0.00 | 4,074.0000 | 19,782,000 | 9999.99% | 0.02% |
| June 17, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | D | Stock Option (Right to Buy) | 13999 | $0.00 | 0.0000 | 19,782,000 | 100.00% | 0.07% |
| June 17, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | A | Stock Option (Right to Buy) | 13999 | $0.00 | 13,999.0000 | 19,782,000 | 9999.99% | 0.07% |
| June 17, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | D | Stock Option (Right to Buy) | 15999 | $0.00 | 0.0000 | 19,782,000 | 100.00% | 0.08% |
| June 17, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | A | Stock Option (Right to Buy) | 15999 | $0.00 | 15,999.0000 | 19,782,000 | 9999.99% | 0.08% |
| June 17, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | D | Stock Option (Right to Buy) | 25500 | $0.00 | 0.0000 | 19,782,000 | 100.00% | 0.13% |
| June 17, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | A | Stock Option (Right to Buy) | 25500 | $0.00 | 25,500.0000 | 19,782,000 | 9999.99% | 0.13% |
| June 17, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | D | Stock Option (Right to Buy) | 13000 | $0.00 | 0.0000 | 19,782,000 | 100.00% | 0.07% |
| June 17, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | A | Stock Option (Right to Buy) | 13000 | $0.00 | 13,000.0000 | 19,782,000 | 9999.99% | 0.07% |
| June 17, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | D | Stock Option (Right to Buy) | 23092 | $0.00 | 0.0000 | 19,782,000 | 100.00% | 0.12% |
| June 17, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | A | Stock Option (Right to Buy) | 23092 | $0.00 | 23,092.0000 | 19,782,000 | 9999.99% | 0.12% |
| June 17, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | D | Stock Option (Right to Buy) | 16384 | $0.00 | 0.0000 | 19,782,000 | 100.00% | 0.08% |
| May 15, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | S | Common Stock | 2960 | $2.00 | 39,154.0000 | 19,782,000 | 7.03% | 0.01% |
| Feb. 25, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | A | Stock Option (Right to Buy) | 78750 | $0.00 | 78,750.0000 | 19,782,000 | 9999.99% | 0.40% |
| Feb. 25, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | A | Common Stock | 13125 | $0.00 | 42,114.0000 | 19,782,000 | 45.28% | 0.07% |
| Aug. 2, 2024 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | A | Stock Option (Right to Buy) | 64394 | $0.00 | 64,394.0000 | 20,852,000 | 9999.99% | 0.31% |
| Oct. 3, 2023 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | A | Stock Option (Right to Buy) | 130000 | $0.00 | 130,000.0000 | 10,099,000 | 9999.99% | 1.29% |
| Feb. 12, 2024 | Adverum Biotechnologies, Inc. | $ADVM | Soparkar Peter | CHIEF OPERATING OFFICER | A | Stock Option (Right to Buy) | 450000 | $0.00 | 450,000.0000 | 10,082,000 | 9999.99% | 4.46% |